Journal: Biochemical and biophysical research communications
Article Title: Low expression of Frataxin might contribute to diabetic peripheral neuropathy in a mouse model.
doi: 10.1016/j.bbrc.2024.151228
Figure Lengend Snippet: Fig. 4. SS-31 improves mitochondrial function and ameliorates inflammation in sciatic nerves of db/db mice by elevating the expression of Fxn. β-actin is used as an internal control if not specified in this figure and later. (A, B) SS-31 increases the expression of Fxn, revealed by immunoblotting, in SCN of SS-31-treated db/db mice. n = 6. (C-E) Expression of Ndufs1 and SdhB proteins in SCN of SS-31-treated db/db mice. n = 6. (F, G) Fe–S dependent aconitase activity in SCN. n = 6. Middle panel showed the protein levels of Aco2. (H) The activities of mitochondrial respiratory complex I (NADH-ubiquinone oxidoreductase), determined using spectrophotometry. n = 3. (I–K) qRT-PCR analysis of sciatic nerve mRNA levels of pro-inflammatory cytokines (Il-6, Tnf-α, and Il-1β) after SS-31 treatment. n = 3. Data are mean ± SD. kDa: molecular weight in kilodalton. ANOVA was used for significance. *P < 0.05, **P < 0.01, ***P < 0.001.
Article Snippet: The primary antibodies used are as follows: anti-Ndufs1 (Proteintech, catalog number 12444-1-AP), anti-Rabbit Aco2 (Proteintech, cat# 11,134–1-AP), anti-Ho-1 (Cell Signaling Technology, catalog number 70081 S), anti-Ftl (Abcam, cat# 69,090), anti-SDHB (Abcam, catalog number 178423), and polyclonal antibodies against Fxn and FtH (homemade, prepared from rabbits).
Techniques: Expressing, Control, Western Blot, Activity Assay, Spectrophotometry, Quantitative RT-PCR, Molecular Weight